LDHA and neoplasm: Furthermore, a novel STAT3 inhibitor, LLL12, suppresses ALDH+ and ALDH+/CD44+/CD24− subpopulations of breast cancer cells in vitro and inhibits tumor growth in mouse xenograft and mammary fat pad models in vivo.